Loading…

Catheter, surgical, or hybrid procedure: what future for atrial fibrillation ablation?

Background The debate on the best treatment strategy for atrial fibrillation (AF) has expanded following the introduction of the so-called "hybrid procedure" that combines minimally invasive epicardial ablation with endocardial catheter ablation. However, the advantage of the hybrid approa...

Full description

Saved in:
Bibliographic Details
Published in:Journal of cardiothoracic surgery 2021-06, Vol.16 (1), p.1-186, Article 186
Main Authors: Nasso, Giuseppe, Lorusso, Roberto, Moscarelli, Marco, De Martino, Giuseppe, Dell’Aquila, Angelo M., Motekallemi, Arash, Di Bari, Nicola, Condello, Ignazio, Mastroroberto, Pasquale, Santarpino, Giuseppe, Speziale, Giuseppe
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c540t-5a6fcb257898aea792942ce9b9795f66d2e7a04753a263ce6f426a3217005cfc3
cites cdi_FETCH-LOGICAL-c540t-5a6fcb257898aea792942ce9b9795f66d2e7a04753a263ce6f426a3217005cfc3
container_end_page 186
container_issue 1
container_start_page 1
container_title Journal of cardiothoracic surgery
container_volume 16
creator Nasso, Giuseppe
Lorusso, Roberto
Moscarelli, Marco
De Martino, Giuseppe
Dell’Aquila, Angelo M.
Motekallemi, Arash
Di Bari, Nicola
Condello, Ignazio
Mastroroberto, Pasquale
Santarpino, Giuseppe
Speziale, Giuseppe
description Background The debate on the best treatment strategy for atrial fibrillation (AF) has expanded following the introduction of the so-called "hybrid procedure" that combines minimally invasive epicardial ablation with endocardial catheter ablation. However, the advantage of the hybrid approach over conventional epicardial ablation remains to be established. Methods From June 2008 to December 2020, 609 surgical AF ablation procedures through a right minithoracotomy were performed at our institution. From 2008 to 2011, a unipolar radiofrequency (RF) device was used, whereas from 2011 to 2020 a bipolar RF device was used. In addition, between September 2016 and April 2017, 60 patients underwent endocardial completion of epicardial linear ablation. In 30 of these latter patients, surgical isolation of the Bachmann's bundle (BB) was also performed. Starting from 2021, surviving patients at follow-up were asked to undergo electrocardiographic evaluation and left ventricular function assessment and to complete a questionnaire addressing quality of life and predisposing factors for recurrent AF. Results The ablation procedure was completed in all patients. Upon discharge, 30 (4.9%) patients showed recurrence of AF, whereas the remaining patients (95.1%) were in sinus rhythm. All patients in whom a hybrid approach was used either with or without BB ablation were discharged in sinus rhythm. After a mean follow-up of 74 months, 122 (20%) patients developed recurrent AF, including 19.9% in whom a unipolar RF device was used, 21% in whom a bipolar RF device was used, 23% who had undergone a hybrid procedure without BB ablation and 3.3% who had undergone a hybrid procedure with BB ablation. On multivariate analysis, reduced left ventricular ejection fraction, worsening of European Heart Rhythm Association symptom class, and cognitive impairment or depression during follow-up were found to be significantly associated with AF recurrence. Conclusions Surgical AF ablation through a right minithoracotomy is safe and may allow the creation of additional linear lesions, particularly in the BB. The placement of adjunctive linear lesions in the setting of a hybrid procedure can be more effective in reducing the risk for AF recurrence than isolated surgical ablation or hybrid ablation without the addition of further linear lesions, with no incremental risk to the patient. Keywords: Surgical ablation of atrial fibrillation, Catheter ablation of atrial fibrillation, Hybrid ablation o
doi_str_mv 10.1186/s13019-021-01565-0
format article
fullrecord <record><control><sourceid>gale_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_5a945c8aa2d54037bb329144e5b57384</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A672268139</galeid><doaj_id>oai_doaj_org_article_5a945c8aa2d54037bb329144e5b57384</doaj_id><sourcerecordid>A672268139</sourcerecordid><originalsourceid>FETCH-LOGICAL-c540t-5a6fcb257898aea792942ce9b9795f66d2e7a04753a263ce6f426a3217005cfc3</originalsourceid><addsrcrecordid>eNptUsluFDEQtRCIhIEf4NQSFw7p4H3hQBSNWCJF4gJcrWq3PeNRT3uwu0H5ezzpCBiEfXAtr16pyg-hlwRfEqLlm0IYJqbFlLSYCCla_AidE8VNq7HBj_-yz9CzUnYYc8GweIrOGD-mCDlH39Ywbf3k80VT5ryJDoaLJuVme9fl2DeHnJzv5-zfNj-3MDVhnqrThIqAKUcYmhArcBhgimlsoFuMq-foSYCh-BcP7wp9_fD-y_pTe_v54836-rZ1guOpFSCD66hQ2mjwoAw1nDpvOqOMCFL21CvAXAkGVDLnZeBUAqNEYSxccGyFbhbePsHOHnLcQ76zCaK9D6S8sZCn6AZvBRgunAagfe3NVNcxagjnXnRCMc0r17uF6zB3e987P04ZhhPS08wYt3aTflhNmaz_UQlePxDk9H32ZbL7WJyvyxl9moulggtjJKtnhV79A92lOY91VRUlqCZSaPwHtYE6QBxDqn3dkdReS0Wp1ISZirr8D6re3u-jS6MPscZPCuhS4HIqJfvwe0aC7VFZdlGWrcqy98qymP0ChKi9IA</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2552816580</pqid></control><display><type>article</type><title>Catheter, surgical, or hybrid procedure: what future for atrial fibrillation ablation?</title><source>Publicly Available Content Database</source><source>PubMed Central</source><creator>Nasso, Giuseppe ; Lorusso, Roberto ; Moscarelli, Marco ; De Martino, Giuseppe ; Dell’Aquila, Angelo M. ; Motekallemi, Arash ; Di Bari, Nicola ; Condello, Ignazio ; Mastroroberto, Pasquale ; Santarpino, Giuseppe ; Speziale, Giuseppe</creator><creatorcontrib>Nasso, Giuseppe ; Lorusso, Roberto ; Moscarelli, Marco ; De Martino, Giuseppe ; Dell’Aquila, Angelo M. ; Motekallemi, Arash ; Di Bari, Nicola ; Condello, Ignazio ; Mastroroberto, Pasquale ; Santarpino, Giuseppe ; Speziale, Giuseppe</creatorcontrib><description>Background The debate on the best treatment strategy for atrial fibrillation (AF) has expanded following the introduction of the so-called "hybrid procedure" that combines minimally invasive epicardial ablation with endocardial catheter ablation. However, the advantage of the hybrid approach over conventional epicardial ablation remains to be established. Methods From June 2008 to December 2020, 609 surgical AF ablation procedures through a right minithoracotomy were performed at our institution. From 2008 to 2011, a unipolar radiofrequency (RF) device was used, whereas from 2011 to 2020 a bipolar RF device was used. In addition, between September 2016 and April 2017, 60 patients underwent endocardial completion of epicardial linear ablation. In 30 of these latter patients, surgical isolation of the Bachmann's bundle (BB) was also performed. Starting from 2021, surviving patients at follow-up were asked to undergo electrocardiographic evaluation and left ventricular function assessment and to complete a questionnaire addressing quality of life and predisposing factors for recurrent AF. Results The ablation procedure was completed in all patients. Upon discharge, 30 (4.9%) patients showed recurrence of AF, whereas the remaining patients (95.1%) were in sinus rhythm. All patients in whom a hybrid approach was used either with or without BB ablation were discharged in sinus rhythm. After a mean follow-up of 74 months, 122 (20%) patients developed recurrent AF, including 19.9% in whom a unipolar RF device was used, 21% in whom a bipolar RF device was used, 23% who had undergone a hybrid procedure without BB ablation and 3.3% who had undergone a hybrid procedure with BB ablation. On multivariate analysis, reduced left ventricular ejection fraction, worsening of European Heart Rhythm Association symptom class, and cognitive impairment or depression during follow-up were found to be significantly associated with AF recurrence. Conclusions Surgical AF ablation through a right minithoracotomy is safe and may allow the creation of additional linear lesions, particularly in the BB. The placement of adjunctive linear lesions in the setting of a hybrid procedure can be more effective in reducing the risk for AF recurrence than isolated surgical ablation or hybrid ablation without the addition of further linear lesions, with no incremental risk to the patient. Keywords: Surgical ablation of atrial fibrillation, Catheter ablation of atrial fibrillation, Hybrid ablation of atrial fibrillation</description><identifier>ISSN: 1749-8090</identifier><identifier>EISSN: 1749-8090</identifier><identifier>DOI: 10.1186/s13019-021-01565-0</identifier><identifier>PMID: 34174911</identifier><language>eng</language><publisher>London: BioMed Central Ltd</publisher><subject>Ablation ; Ablation (Surgery) ; Alcohol ; Analysis ; Atrial fibrillation ; Caffeine ; Cardiac arrhythmia ; Catheter ablation of atrial fibrillation ; Catheters ; Cognitive ability ; Diabetes ; Drug therapy ; Ejection fraction ; Fibrillation ; Heart ; Heart beat ; Hybrid ablation of atrial fibrillation ; Hypertension ; Lesions ; Medical instruments ; Multivariate analysis ; Patients ; Quality of life ; Questionnaires ; Radio frequency ; Rhythm ; Statistical analysis ; Surgery ; Surgical ablation of atrial fibrillation ; Thoracic surgery ; Ventricle</subject><ispartof>Journal of cardiothoracic surgery, 2021-06, Vol.16 (1), p.1-186, Article 186</ispartof><rights>COPYRIGHT 2021 BioMed Central Ltd.</rights><rights>2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>The Author(s) 2021</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c540t-5a6fcb257898aea792942ce9b9795f66d2e7a04753a263ce6f426a3217005cfc3</citedby><cites>FETCH-LOGICAL-c540t-5a6fcb257898aea792942ce9b9795f66d2e7a04753a263ce6f426a3217005cfc3</cites><orcidid>0000-0002-4913-9834</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8236186/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2552816580?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25753,27924,27925,37012,37013,44590,53791,53793</link.rule.ids></links><search><creatorcontrib>Nasso, Giuseppe</creatorcontrib><creatorcontrib>Lorusso, Roberto</creatorcontrib><creatorcontrib>Moscarelli, Marco</creatorcontrib><creatorcontrib>De Martino, Giuseppe</creatorcontrib><creatorcontrib>Dell’Aquila, Angelo M.</creatorcontrib><creatorcontrib>Motekallemi, Arash</creatorcontrib><creatorcontrib>Di Bari, Nicola</creatorcontrib><creatorcontrib>Condello, Ignazio</creatorcontrib><creatorcontrib>Mastroroberto, Pasquale</creatorcontrib><creatorcontrib>Santarpino, Giuseppe</creatorcontrib><creatorcontrib>Speziale, Giuseppe</creatorcontrib><title>Catheter, surgical, or hybrid procedure: what future for atrial fibrillation ablation?</title><title>Journal of cardiothoracic surgery</title><description>Background The debate on the best treatment strategy for atrial fibrillation (AF) has expanded following the introduction of the so-called "hybrid procedure" that combines minimally invasive epicardial ablation with endocardial catheter ablation. However, the advantage of the hybrid approach over conventional epicardial ablation remains to be established. Methods From June 2008 to December 2020, 609 surgical AF ablation procedures through a right minithoracotomy were performed at our institution. From 2008 to 2011, a unipolar radiofrequency (RF) device was used, whereas from 2011 to 2020 a bipolar RF device was used. In addition, between September 2016 and April 2017, 60 patients underwent endocardial completion of epicardial linear ablation. In 30 of these latter patients, surgical isolation of the Bachmann's bundle (BB) was also performed. Starting from 2021, surviving patients at follow-up were asked to undergo electrocardiographic evaluation and left ventricular function assessment and to complete a questionnaire addressing quality of life and predisposing factors for recurrent AF. Results The ablation procedure was completed in all patients. Upon discharge, 30 (4.9%) patients showed recurrence of AF, whereas the remaining patients (95.1%) were in sinus rhythm. All patients in whom a hybrid approach was used either with or without BB ablation were discharged in sinus rhythm. After a mean follow-up of 74 months, 122 (20%) patients developed recurrent AF, including 19.9% in whom a unipolar RF device was used, 21% in whom a bipolar RF device was used, 23% who had undergone a hybrid procedure without BB ablation and 3.3% who had undergone a hybrid procedure with BB ablation. On multivariate analysis, reduced left ventricular ejection fraction, worsening of European Heart Rhythm Association symptom class, and cognitive impairment or depression during follow-up were found to be significantly associated with AF recurrence. Conclusions Surgical AF ablation through a right minithoracotomy is safe and may allow the creation of additional linear lesions, particularly in the BB. The placement of adjunctive linear lesions in the setting of a hybrid procedure can be more effective in reducing the risk for AF recurrence than isolated surgical ablation or hybrid ablation without the addition of further linear lesions, with no incremental risk to the patient. Keywords: Surgical ablation of atrial fibrillation, Catheter ablation of atrial fibrillation, Hybrid ablation of atrial fibrillation</description><subject>Ablation</subject><subject>Ablation (Surgery)</subject><subject>Alcohol</subject><subject>Analysis</subject><subject>Atrial fibrillation</subject><subject>Caffeine</subject><subject>Cardiac arrhythmia</subject><subject>Catheter ablation of atrial fibrillation</subject><subject>Catheters</subject><subject>Cognitive ability</subject><subject>Diabetes</subject><subject>Drug therapy</subject><subject>Ejection fraction</subject><subject>Fibrillation</subject><subject>Heart</subject><subject>Heart beat</subject><subject>Hybrid ablation of atrial fibrillation</subject><subject>Hypertension</subject><subject>Lesions</subject><subject>Medical instruments</subject><subject>Multivariate analysis</subject><subject>Patients</subject><subject>Quality of life</subject><subject>Questionnaires</subject><subject>Radio frequency</subject><subject>Rhythm</subject><subject>Statistical analysis</subject><subject>Surgery</subject><subject>Surgical ablation of atrial fibrillation</subject><subject>Thoracic surgery</subject><subject>Ventricle</subject><issn>1749-8090</issn><issn>1749-8090</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNptUsluFDEQtRCIhIEf4NQSFw7p4H3hQBSNWCJF4gJcrWq3PeNRT3uwu0H5ezzpCBiEfXAtr16pyg-hlwRfEqLlm0IYJqbFlLSYCCla_AidE8VNq7HBj_-yz9CzUnYYc8GweIrOGD-mCDlH39Ywbf3k80VT5ryJDoaLJuVme9fl2DeHnJzv5-zfNj-3MDVhnqrThIqAKUcYmhArcBhgimlsoFuMq-foSYCh-BcP7wp9_fD-y_pTe_v54836-rZ1guOpFSCD66hQ2mjwoAw1nDpvOqOMCFL21CvAXAkGVDLnZeBUAqNEYSxccGyFbhbePsHOHnLcQ76zCaK9D6S8sZCn6AZvBRgunAagfe3NVNcxagjnXnRCMc0r17uF6zB3e987P04ZhhPS08wYt3aTflhNmaz_UQlePxDk9H32ZbL7WJyvyxl9moulggtjJKtnhV79A92lOY91VRUlqCZSaPwHtYE6QBxDqn3dkdReS0Wp1ISZirr8D6re3u-jS6MPscZPCuhS4HIqJfvwe0aC7VFZdlGWrcqy98qymP0ChKi9IA</recordid><startdate>20210626</startdate><enddate>20210626</enddate><creator>Nasso, Giuseppe</creator><creator>Lorusso, Roberto</creator><creator>Moscarelli, Marco</creator><creator>De Martino, Giuseppe</creator><creator>Dell’Aquila, Angelo M.</creator><creator>Motekallemi, Arash</creator><creator>Di Bari, Nicola</creator><creator>Condello, Ignazio</creator><creator>Mastroroberto, Pasquale</creator><creator>Santarpino, Giuseppe</creator><creator>Speziale, Giuseppe</creator><general>BioMed Central Ltd</general><general>BioMed Central</general><general>BMC</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M7Z</scope><scope>P64</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0002-4913-9834</orcidid></search><sort><creationdate>20210626</creationdate><title>Catheter, surgical, or hybrid procedure: what future for atrial fibrillation ablation?</title><author>Nasso, Giuseppe ; Lorusso, Roberto ; Moscarelli, Marco ; De Martino, Giuseppe ; Dell’Aquila, Angelo M. ; Motekallemi, Arash ; Di Bari, Nicola ; Condello, Ignazio ; Mastroroberto, Pasquale ; Santarpino, Giuseppe ; Speziale, Giuseppe</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c540t-5a6fcb257898aea792942ce9b9795f66d2e7a04753a263ce6f426a3217005cfc3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Ablation</topic><topic>Ablation (Surgery)</topic><topic>Alcohol</topic><topic>Analysis</topic><topic>Atrial fibrillation</topic><topic>Caffeine</topic><topic>Cardiac arrhythmia</topic><topic>Catheter ablation of atrial fibrillation</topic><topic>Catheters</topic><topic>Cognitive ability</topic><topic>Diabetes</topic><topic>Drug therapy</topic><topic>Ejection fraction</topic><topic>Fibrillation</topic><topic>Heart</topic><topic>Heart beat</topic><topic>Hybrid ablation of atrial fibrillation</topic><topic>Hypertension</topic><topic>Lesions</topic><topic>Medical instruments</topic><topic>Multivariate analysis</topic><topic>Patients</topic><topic>Quality of life</topic><topic>Questionnaires</topic><topic>Radio frequency</topic><topic>Rhythm</topic><topic>Statistical analysis</topic><topic>Surgery</topic><topic>Surgical ablation of atrial fibrillation</topic><topic>Thoracic surgery</topic><topic>Ventricle</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Nasso, Giuseppe</creatorcontrib><creatorcontrib>Lorusso, Roberto</creatorcontrib><creatorcontrib>Moscarelli, Marco</creatorcontrib><creatorcontrib>De Martino, Giuseppe</creatorcontrib><creatorcontrib>Dell’Aquila, Angelo M.</creatorcontrib><creatorcontrib>Motekallemi, Arash</creatorcontrib><creatorcontrib>Di Bari, Nicola</creatorcontrib><creatorcontrib>Condello, Ignazio</creatorcontrib><creatorcontrib>Mastroroberto, Pasquale</creatorcontrib><creatorcontrib>Santarpino, Giuseppe</creatorcontrib><creatorcontrib>Speziale, Giuseppe</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Biochemistry Abstracts 1</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>Directory of Open Access Journals</collection><jtitle>Journal of cardiothoracic surgery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Nasso, Giuseppe</au><au>Lorusso, Roberto</au><au>Moscarelli, Marco</au><au>De Martino, Giuseppe</au><au>Dell’Aquila, Angelo M.</au><au>Motekallemi, Arash</au><au>Di Bari, Nicola</au><au>Condello, Ignazio</au><au>Mastroroberto, Pasquale</au><au>Santarpino, Giuseppe</au><au>Speziale, Giuseppe</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Catheter, surgical, or hybrid procedure: what future for atrial fibrillation ablation?</atitle><jtitle>Journal of cardiothoracic surgery</jtitle><date>2021-06-26</date><risdate>2021</risdate><volume>16</volume><issue>1</issue><spage>1</spage><epage>186</epage><pages>1-186</pages><artnum>186</artnum><issn>1749-8090</issn><eissn>1749-8090</eissn><abstract>Background The debate on the best treatment strategy for atrial fibrillation (AF) has expanded following the introduction of the so-called "hybrid procedure" that combines minimally invasive epicardial ablation with endocardial catheter ablation. However, the advantage of the hybrid approach over conventional epicardial ablation remains to be established. Methods From June 2008 to December 2020, 609 surgical AF ablation procedures through a right minithoracotomy were performed at our institution. From 2008 to 2011, a unipolar radiofrequency (RF) device was used, whereas from 2011 to 2020 a bipolar RF device was used. In addition, between September 2016 and April 2017, 60 patients underwent endocardial completion of epicardial linear ablation. In 30 of these latter patients, surgical isolation of the Bachmann's bundle (BB) was also performed. Starting from 2021, surviving patients at follow-up were asked to undergo electrocardiographic evaluation and left ventricular function assessment and to complete a questionnaire addressing quality of life and predisposing factors for recurrent AF. Results The ablation procedure was completed in all patients. Upon discharge, 30 (4.9%) patients showed recurrence of AF, whereas the remaining patients (95.1%) were in sinus rhythm. All patients in whom a hybrid approach was used either with or without BB ablation were discharged in sinus rhythm. After a mean follow-up of 74 months, 122 (20%) patients developed recurrent AF, including 19.9% in whom a unipolar RF device was used, 21% in whom a bipolar RF device was used, 23% who had undergone a hybrid procedure without BB ablation and 3.3% who had undergone a hybrid procedure with BB ablation. On multivariate analysis, reduced left ventricular ejection fraction, worsening of European Heart Rhythm Association symptom class, and cognitive impairment or depression during follow-up were found to be significantly associated with AF recurrence. Conclusions Surgical AF ablation through a right minithoracotomy is safe and may allow the creation of additional linear lesions, particularly in the BB. The placement of adjunctive linear lesions in the setting of a hybrid procedure can be more effective in reducing the risk for AF recurrence than isolated surgical ablation or hybrid ablation without the addition of further linear lesions, with no incremental risk to the patient. Keywords: Surgical ablation of atrial fibrillation, Catheter ablation of atrial fibrillation, Hybrid ablation of atrial fibrillation</abstract><cop>London</cop><pub>BioMed Central Ltd</pub><pmid>34174911</pmid><doi>10.1186/s13019-021-01565-0</doi><orcidid>https://orcid.org/0000-0002-4913-9834</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1749-8090
ispartof Journal of cardiothoracic surgery, 2021-06, Vol.16 (1), p.1-186, Article 186
issn 1749-8090
1749-8090
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_5a945c8aa2d54037bb329144e5b57384
source Publicly Available Content Database; PubMed Central
subjects Ablation
Ablation (Surgery)
Alcohol
Analysis
Atrial fibrillation
Caffeine
Cardiac arrhythmia
Catheter ablation of atrial fibrillation
Catheters
Cognitive ability
Diabetes
Drug therapy
Ejection fraction
Fibrillation
Heart
Heart beat
Hybrid ablation of atrial fibrillation
Hypertension
Lesions
Medical instruments
Multivariate analysis
Patients
Quality of life
Questionnaires
Radio frequency
Rhythm
Statistical analysis
Surgery
Surgical ablation of atrial fibrillation
Thoracic surgery
Ventricle
title Catheter, surgical, or hybrid procedure: what future for atrial fibrillation ablation?
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T14%3A48%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Catheter,%20surgical,%20or%20hybrid%20procedure:%20what%20future%20for%20atrial%20fibrillation%20ablation?&rft.jtitle=Journal%20of%20cardiothoracic%20surgery&rft.au=Nasso,%20Giuseppe&rft.date=2021-06-26&rft.volume=16&rft.issue=1&rft.spage=1&rft.epage=186&rft.pages=1-186&rft.artnum=186&rft.issn=1749-8090&rft.eissn=1749-8090&rft_id=info:doi/10.1186/s13019-021-01565-0&rft_dat=%3Cgale_doaj_%3EA672268139%3C/gale_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c540t-5a6fcb257898aea792942ce9b9795f66d2e7a04753a263ce6f426a3217005cfc3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2552816580&rft_id=info:pmid/34174911&rft_galeid=A672268139&rfr_iscdi=true